Results 131 to 140 of about 6,153 (148)

Survival characteristics of localized pediatric adrenocortical carcinoma managed with adenectomy: A national cancer center database analysis

Journal of Pediatric Urology, 2021
Pediatric adrenocortical carcinoma (ACC) is a rare malignancy, encompassing less than 0.2% of all childhood malignancies. Due to the scarcity of this diagnosis, it is often managed according to guidelines established for adults, as there is a lack of reliable evidence regarding optimal adjuvant treatment options for pediatric patients. It is our aim to
Jaisa D. Evanoff, Sanjay G. Patel, Kyle J. Hickey, Adam J. Rensing   +3 more
openaire   +2 more sources

Rare Pediatric Adrenocortical Carcinoma with Oncocytic Change: A Cytologic Dilemma

Endocrine Pathology, 2010
Pediatric adrenocortical carcinoma is extremely rare with a prevalence of 0.3 per million. Adrenocortical neoplasms in children usually present with one of the endocrine abnormalities. Adrenocortical neoplasms cannot be easily diagnosed on cytopathology; hence, the cytomorphological features posing diagnostic dilemmas are discussed in a pediatric ...
Savita, Agarwal, Kiran, Agarwal
openaire   +2 more sources

Pediatric adrenocortical neoplasms: can imaging reliably discriminate adenomas from carcinomas?

Pediatric Radiology, 2015
There is a paucity of literature describing and comparing the imaging features of adrenocortical adenomas and carcinomas in children and adolescents.To document the CT and MRI features of adrenocortical neoplasms in a pediatric population and to determine whether imaging findings (other than metastatic disease) can distinguish adenomas from carcinomas ...
Kelsey A, Flynt, Jonathan R, Dillman, Matthew S, Davenport, Ethan A, Smith, Tobias, Else, Peter J, Strouse, Elaine M, Caoili   +6 more
openaire   +2 more sources

Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma

Endocrine-Related Cancer
Adrenocortical carcinoma (ACC) is a malignancy with a poor prognosis and high mortality rate. A high tumor mutational burden (TMB) has been found to be associated with poor prognosis in ACC. Thus, exploring ACC biomarkers based on TMB holds significant importance for patient risk stratification.
Yihao Chen, Jiahong Chen, Yongcheng Shi, Xiaohui Ling, Shumin Fang, Chuanfan Zhong, Fengping Liu, Weide Zhong, Xuecheng Bi, Zhong Dong, Jianming Lu   +10 more
openaire   +2 more sources

Predictors of survival in pediatric adrenocortical carcinoma: A Surveillance, Epidemiology, and End Results (SEER) program study

Journal of Pediatric Surgery, 2013
Adrenocortical carcinoma (ACC) is rarely described in children. There is variation in incidence worldwide. This study sought to identify national incidence rates and independent prognostic indicators for children.The SEER database was queried for the years 1973 through 2008 for all patients with ACC less than 20 years of age.
Jarod P, McAteer, Jorge A, Huaco, Kenneth W, Gow   +2 more
openaire   +2 more sources

Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination

Journal of Pediatric Hematology/Oncology, 2017
Childhood adrenocortical carcinoma (ACC) is a rare tumor and its association with acute lymphoblastic leukemia (ALL) is even rarer. One such case is discussed in this case report. A 3-year-old patient was concomitantly diagnosed with ALL and an initially nonmetastatic ACC.
Wafaa M, Rashed, Wael, Zekri, Madiha, Awad, Hala, Taha, Badr, Abdalla, Ahmad S, Alfaar   +5 more
openaire   +2 more sources

Label-free impedimetric immunosensor based on arginine-functionalized gold nanoparticles for detection of DHEAS, a biomarker of pediatric adrenocortical carcinoma

Biosensors and Bioelectronics, 2019
Pediatric adrenocortical carcinoma (pACC) is a rare and aggressive malignancy of high occurrence in Southern Brazil. pACC is characterized by the usual overproduction of dehydroepiandrosterone sulfate (DHEAS), whose detection in serum or plasma can be effective to the early diagnosis of the disease.
Dhésmon, Lima, Juliana, Inaba, Luma, Clarindo Lopes, Giselle Nathaly, Calaça, Patrícia, Los Weinert, Rafaela, Lenzi Fogaça, Juliana, Ferreira de Moura, Larissa, Magalhães Alvarenga, Bonald, Cavalcante de Figueiredo, Karen, Wohnrath, Christiana, Andrade Pessôa   +10 more
openaire   +2 more sources

Outcome and prognostic factors in high‐risk childhood adrenocortical carcinomas: A report from the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT)

Pediatric Blood & Cancer, 2016
AbstractObjectivesThe aim of this retrospective international analysis was to evaluate the role of risk factors in pediatric patients with adrenocortical carcinoma (ACC) observed in European countries (2000–2013) in an attempt to identify factors associated with poor prognosis.ProceduresData were retrieved from databases of Germany, France, Poland, and
CECCHETTO, GIOVANNI, GANARIN, ALBA, Bien, Ewa, Vorwerk, Peter, BISOGNO, GIANNI, Godzinski, Jan, DALL'IGNA, PATRIZIA, Reguerre, Yves, Schneider, Dominik, Brugières, Laurence, Leblond, Pierre, Ferrari, Andrea, Brecht, Ines, DE PAOLI, ANGELA, Orbach, Daniel   +14 more
openaire   +3 more sources

Report on 5 cases of pediatric adrenocortical carcinoma

The Journal of the Japanese Society of Clinical Cytology, 2010
Yasue SHITARA, Yukie SHOHNO, Tadanari IWATA, Ryuji FUKUZAWA, Yukihiko MORIKAWA   +4 more
openaire   +1 more source

Comparison of 68Ga-FAPI and 18F-FDG PET/CT Findings in Oncocytic and Conventional Subtypes of Pediatric Adrenocortical Carcinoma

Clinical Nuclear Medicine
Abstract Adrenocortical carcinoma, a poor prognosis cancer with a low survival rate, is a rare pediatric malignancy. We performed 18F-FDG PET/CT and 68Ga-FAPI PET/CT imaging in 2 children with different subtypes of adrenocortical carcinoma and compared the findings.
Elnaz Jenabi, Hamidreza Amini, Bababk Nikkholgh, Ghasemali Divband   +3 more
openaire   +2 more sources